Search
Displaying 301–310 of 994 results
-
“My dream career was to be a magazine or newspaper photographer,” recounts Ryck Lent. However, on a day in 1980, just before turning 30, he received a life-altering diagnosis: retinitis pigmentosa (RP). “After that, I knew my life was headed down a different path.”
-
Pat lives in Atlanta and has been working his way up in commercial photography for the last 8 years. He was recently diagnosed with retinitis pigmentosa at age 31.
-
Nicole Rubio was born in New York and graduated from the Museum School of Fine Arts, Boston. She migrated to the West Coast and was diagnosed with retinitis pigmentosa in 1978.
-
Lisa Pleasants is a carrier for x-linked juvenile retinoschisis. She has a son, two brothers and a cousin with the disease. She has lived with this disease in her family for generations and knows firsthand that it’s not easy.
-
My name is Terry Super. As a Professional Engineer, my career was defined by technical and left-brained stuff. Today, I’m semi-retired and have been relaxing by doing some creative and right-brained stuff - oil painting.
-
Erin Halford is a visual artist, writer, and educator who lives in the greater Los Angeles area. She graduated with her MFA in Studio from the School of the Art Institute of Chicago in 2017, and she has exhibited her art throughout the United States, as well as in the United Kingdom and in Japan. Schalk’s artwork and writing have also been published in a variety of literary journals.
-
Colin was born in the small Western New York Community of Jamestown. His emersion into the arts started naturally, his mother was a designer and his father an art and antiques collector.
-
Alley Morgan is from Dayton, Ohio. She has an inexhaustible love of wildlife and art. By combining those interests, she specializes in creating fun and goofy animals characters with personality and attitude.
-
“Eye of the Beholder” was initiated by two artists — both affected by retinal disease, and who are very well aware of the significance of such a contribution. For some, our artwork is an important source of income; for all, it is a deeply personal pursuit.
-
RD Fund Participates in a €75 Million Series B for SparingVision
In the PressProceeds to fund first, in-human trials of breakthrough gene-agnostic therapy products and advance CRISPR-based genome editing portfolio.
